Inter Partes Challenge Filed Against Myriad Patents

Following a bruising U.S. Supreme Court fight last year that invalidated two of its human gene patents, Myriad Genetics Inc. is using related patents to sue a new set of competitors—but faces an aggressive counterattack.

Sign up for a free trial now!'s Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on
  • The free InPractice digital newsletter
  • Personalized legal news on the mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Newswire digital newsletter.